T3	Subject 2 53	71-year-old man with paroxysmal atrial fibrillation
T4	Treatment 170 218	oral sustained-release procainamide (750 mg/day)
T6	Effect 114 130	granulocytopenia
T8	Age 2 13	71-year-old
T9	Gender 14 17	man
T10	Time_elapsed 131 137	8 days
T11	Drug 175 205	sustained-release procainamide
T12	Route 170 174	oral
T13	Dosage 207 217	750 mg/day
T15	Treat-Disorder 23 53	paroxysmal atrial fibrillation
T16	Sub-Disorder 73 103	anterior myocardial infarction
